Evidence map›Paper›PMID 26028628›Full record

SynthesisEuropean respiratory review : an official journal of the European Respiratory Society2015

An official American Thoracic Society/European Respiratory Society statement: research questions in COPD.

Bartolome R Celli, Marc Decramer, Jadwiga A Wedzicha, Kevin C Wilson, Alvar A Agustí, Gerard J Criner, William MacNee, Barry J Make, Stephen I Rennard, Robert A Stockley and 45 more

Registry-linked trialOpen access · diamondAbstract readSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in European respiratory review : an official journal of the European Respiratory Society, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04231058 (The Effects of Acu-TENS in the Non-pharmacological Treatment of Dyspnea in Chronic Obstructive Pulmonary Disease), which is not on this map. Cited by 44 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 3 pooled it
13.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04231058 nasuspendednot on this mapstarted 2024, after this paper: background citation

The Effects of Acu-TENS in the Non-pharmacological Treatment of Dyspnea in Chronic Obstructive Pulmonary Disease (COPD)

TypeinterventionalSponsorAzienda USL Toscana Nord OvestRan2024 to 2024Enrolled30ConditionsDyspneaArmsTENS and pulmonary rehabilitation
3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 3 syntheses or guidelines pooled it, 114 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Sarcopenia in COPD: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2019
    Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Review
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Comparing the utility of lung function parameters and fractional exhaled nitric oxide in predicting lung cancer.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2024
    Article
  17. Article
  18. Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Emphysema.American journal of respiratory cell and molecular biology · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

55 authors at 1 institution in 1 country.

Bartolome R CelliFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Marc DecramerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Jadwiga A WedzichaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Kevin C WilsonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section kwilson@thoracic.org.
Alvar A AgustíFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Gerard J CrinerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
William MacNeeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Barry J MakeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Stephen I RennardFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Robert A StockleyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Claus VogelmeierFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Antonio AnzuetoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
David H AuFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Peter J BarnesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Pierre-Regis BurgelFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Peter M CalverleyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Ciro CasanovaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Enrico M CliniFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Christopher B CooperFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Harvey O CoxsonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Daniel J DusserFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Leonardo M FabbriFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Bonnie FahyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Gary T FergusonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Andrew FisherFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Monica J FletcherFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Maurice HayotFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
John R HurstFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Paul W JonesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Donald A MahlerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
François MaltaisFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
David M ManninoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Fernando J MartinezFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Marc MiravitllesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Paula M MeekFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Alberto PapiFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Klaus F RabeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Nicolas RocheFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Frank C SciurbaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Sanjay SethiFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Nikos SiafakasFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Don D SinFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Joan B SorianoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
James K StollerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Donald P TashkinFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Thierry TroostersFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Geert M VerledenFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Johny VerschakelenFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Jorgen VestboFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
John W WalshFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
George R WashkoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Robert A WiseFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Emiel F M WoutersFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
Richard L ZuWallackFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section.
ATS/ERS Task Force for COPD Research
COPD Foundation · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity, mortality and resource use worldwide. The goal of this official American Thoracic Society (ATS)/European Respiratory Society (ERS) Research Statement is to describe evidence related to diagnosis, assessment, and management; identify gaps in knowledge; and make recommendations for future research. It is not intended to provide clinical practice recommendations on COPD diagnosis and management. Clinicians, researchers and patient advocates with expertise in COPD were invited to participate. A literature search of Medline was performed, and studies deemed relevant were selected. The search was not a systematic review of the evidence. Existing evidence was appraised and summarised, and then salient knowledge gaps were identified. Recommendations for research that addresses important gaps in the evidence in all areas of COPD were formulated via discussion and consensus. Great strides have been made in the diagnosis, assessment and management of COPD, as well as understanding its pathogenesis. Despite this, many important questions remain unanswered. This ATS/ERS research statement highlights the types of research that leading clinicians, researchers and patient advocates believe will have the greatest impact on patient-centred outcomes.

Indexed as

Biomedical ResearchLungPulmonary Disease, Chronic ObstructiveComorbidityConsensusHumansPredictive Value of TestsRespiratory Function TestsRisk FactorsRisk Reduction BehaviorSeverity of Illness IndexTreatment Outcome

Identifiers

PMID26028628
PMCPMC9487818
OpenAlexW1889449109

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.